Regulatory requirements and product attributes for cGMP viral vector production

Navigating the constantly evolving regulatory landscape in cell and gene therapy manufacturing can pose critical challenges for developers and manufacturers. Failure to meet requirements can significantly raise costs, motivating the implementation of robust, reproducible, and compliant processes.

Please enter your email to access content Read now